Bitget App
スマートな取引を実現
暗号資産を購入市場取引先物Bitget Earn広場もっと見る
‌価格
データ
会社概要
RPRX stock price forecast
ニュース
競合相手
トークン化
暗号資産
よくあるご質問
Royalty Pharma plc株式ロゴ

Royalty Pharma plc

RPRX·NASDAQ

最終更新日:2026-02-14 16:10 EST。株価情報はTradingViewからリアルタイムで取得されます。

インサイト
計算機
ニュース

RPRXの株価変動

最終取引日において、RPRX株式の終値は44.80 USDで、1日の価格変動は1.24%でした。
株式先物を取引

Bitgetについて

世界初のユニバーサル取引所(UEX)では、ユーザーは暗号資産だけでなく、株式、ETF、外国為替、金、現実資産(RWA)も取引できます。
詳細を見る

RPRXの主要データ

前日終値44.80 USD
時価総額25.79B USD
取引量5.71M
P/E比率25.16
配当利回り(TTM)1.96%
配当額0.22 USD
最終配当落ち日Nov 14, 2025
最終支払日Dec 10, 2025
希薄化後EPS(TTM)1.78 USD
純利益(年度)858.98M USD
収益(年度)2.26B USD
次回のレポート日Feb 11, 2026
推定EPS1.290 USD
収益見積もり806.96M USD USD
流通株式数388.86M
ベータ(1年)0.36
Tokenized stocks

トークン化された株式について聞いたことがありますか?

株式取引の新しい方法 ― 24時間年中無休、いつでもどこでも。

詳細を見る

Royalty Pharma plcの概要

Royalty Pharma Plcは、医薬品開発サービスの提供に従事しています。同社はバイオ製薬業界全体のイノベーションの資金提供者として、学術機関、研究病院、非営利団体のイノベーターと協力し、中小規模のバイオテクノロジー企業からグローバル製薬企業まで幅広く連携しています。ポートフォリオには、AbbVieおよびJ&JのImbruvica、アステラスとPfizerのXtandi、BiogenのTysabri、GileadのHIVフランチャイズ、MerckのJanuvia、NovartisのPromacta、VertexのKalydeco、Orkambi、Symdeko、Trikafta、さらに5つの開発段階の製品候補のロイヤリティが含まれています。同社は1996年にPablo Gerardo Legorreta氏とRory B. Riggs氏によって設立され、ニューヨーク州ニューヨーク市に本社を置いています。
セクター
ヘルステクノロジー
業種
医薬品:大手
CEO
Pablo Gerardo Legorreta
本部
New York
ウェブサイト
royaltypharma.com
設立
2020
従業員数(年度)
99
変動率(1年)
+10 +11.24%
収益 / 従業員数(1年)
22.86M USD
純利益 / 従業員(1年)
8.68M USD

RPRXの動向

Daily updates on RPRX stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• RPRX株価の24時間変動:+0.09%。44.21米ドルから44.25米ドルへ上昇。セッション中に強力な第4四半期決算の好調と2026年のガイダンスの明るさにより、52週の新高値45.24米ドルを記録した後、やや落ち着きました。
• 技術的観点から見ると、RPRXは「強い強気トレンド」にあり、株価は20日(44.07米ドル)、50日(42.67米ドル)、200日(40.59米ドル)の移動平均線を上回っています。ただし、RSIが72.95と高く、株価が買われ過ぎの領域に入り、直近の年間高値突破後に短期的な調整が予想されます。
• Royalty Pharmaは2025年第4四半期のEPSが1.47米ドル、売上高が8.74億米ドルと、アナリスト予想(EPS 1.25米ドル、売上高7.96億米ドル)を大きく上回り、2026年のポートフォリオ収益見通しも前向きに示しました。
• 同社は1株当たり配当を0.235米ドル(従来は0.22米ドル)に増額し、2026年3月に支払う予定です。これは強力な営業キャッシュフローと、今後1年間で利益が60%拡大する見込みに支えられています。
• ウォール街のセンチメントは依然として強気で、UBSとシティグループは最近、目標株価をそれぞれ49米ドルと50米ドルに引き上げました。これは、同社の規律ある資本配分とバイオファーマロイヤリティ市場でのリーダーシップを評価したものです。
• BridgeBio Pharmaは、口腔投与型軟骨無形成症治療薬infigratinibの第3相試験で主要評価項目を達成し、2026年末の規制申請を計画していると発表し、遺伝子医療への投資家の信頼を高めました。
• 欧州ライフサイエンス連合は2月12日に正式に発足し、EUのバイオテック・ベンチャーキャピタル・エコシステムを強化し、構造的な投資障壁に対処するために、民間と公的投資で240億ユーロを動員することを目指しています。
もっと見る
約2日前
• RPRX株価の24時間変動:-1.02%。44.23米ドルから43.78米ドルへ下落。昨日の下落は、同社の2026年ガイダンスに対する市場の反応が主因であり、ロイヤリティ収入の成長率が3%〜8%と控えめに予測され、2025年の二桁成長と比較して減速を示唆しています。
• テクニカル面では、株価は「買われ過ぎの調整」局面にあり、RSI(14)は70.52に達し、短期的な反落や売りシグナルの可能性を示唆しています。50日($39.56)と200日($36.30)の移動平均線は強気の「ゴールデンクロス」状態を維持していますが、ADXは15.31でトレンドの強さが弱まっており、直近の上昇後は横ばいの展開が予想されます。
• Royalty Pharmaは2月11日に2025年第4四半期の決算を発表し、ポートフォリオ収入は前年比16%増、2026年ガイダンスは32.75億〜34.25億ドルとし、特許切れやバイオシミラー競争による逆風に直面しています。
• 同社は四半期配当を1株当たり0.235ドルに増額し、前年比7%増となり、長期的なキャッシュフローの持続性に対する経営陣の自信を示しています。
• CEOのPablo Legorretaは、資本配分が過去最高となった年を強調し、47億ドルの取引発表や、将来の運営コスト削減を目的とした外部運用者の戦略的な内製化を含みます。
• 富士フイルムは2月11日、英国に5億ドル規模の新しいバイオ医薬品製造施設を開設し、グローバルなバイオ医薬品製造業界の大規模なインフラ投資と成長を示しています。
• 2026年のバイオテク業界の見通しは「慎重な楽観主義」を強調し、資本配分の規律や、細胞特異的デリバリーや希少疾患分野でのグローバルな研究開発競争の激化に焦点を当てています。
もっと見る
約3日前

RPRX stock price forecast

According to technical indicators for RPRX stock, the price is likely to fluctuate within the range of 51.49–54.40 USD over the next week. Market analysts predict that the price of RPRX stock will likely fluctuate within the range of 45.06–55.09 USD over the next months.

Based on 1-year price forecasts from 63 analysts, the highest estimate is 80.14 USD, while the lowest estimate is 29.31 USD.

For more information, please see the RPRX stock price forecast Stock Price Forecast page.

Bitgetアカウントだけで、株式と暗号資産を同時に取引できます。

今すぐ参加

よくあるご質問

Royalty Pharma plcの株価はいくらですか?

RPRXの現在の価格は44.80 USDです — 過去24時間で価格は1.24%変動しました。Royalty Pharma plcの株価動向は、このページ上部の価格チャートでより詳細に追跡できます。

Royalty Pharma plcの株式ティッカーは?

取引所によっては、株式のティッカーが異なる場合があります。例えば、NASDAQでは、Royalty Pharma plcはRPRXというティッカーシンボルで取引されています。

RPRXの株価予測は?

アナリストによるRoyalty Pharma plcの将来価格に関する見解を集めました。彼らの予測によると、RPRXの推定最高値448.00 USD、最低値は89.60 USDとなっています。

Royalty Pharma plcの時価総額は?

Royalty Pharma plcの時価総額は25.79B USDです。

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

リスク警告:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

推奨事項:キャンペーンは予告なく変更または終了する場合がございます。取引時の最新かつ正確なレートについては、Bitget公式の「 Fee overview 」または「 Announcement Center 」ページをご確認ください。

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NASDAQ/
RPRX
© 2026 Bitget